When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AMPE - Ampio completes enrollment in study of Ampion for COVID-19
Ampio Pharmaceuticals Inc.
Ampio Pharmaceuticals (AMPE+2.5%) announces the completion of enrollment in a 10-subject Phase 1 study assessing IV Ampion in COVID-19 patients requiring supplemental oxygen. Final results should be available next week after the Safety Monitoring Committee and principal investigator complete their assessments.
More news on: Ampio Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move,